The company is shipping 50mg and 100mg injection doses.Credit: MargJohnsonVA/Shutterstock. French multinational pharmaceutical company Sanofi has commenced the shipping of BEYFORTUS (nirsevimab-alip) to the US,
The company has set ambitious goals to reduce absolute scope 1 and 2 GHG emissions by 42% by 2030. Credit: Gorodenkoff/Shutterstock. The Science Based Targets
CRSwNP is a chronic inflammatory disease of the upper airway. Credit: Luisella Planeta LOVE PEACE 💛💙 from Pixabay. The US Food and Drug Administration (FDA)
EBGLYSS can be administered with or without topical corticosteroids. Credit: Eli Lilly and Company. Eli Lilly and Company has announced FDA approval of EBGLYSS (lebrikizumab-lbkz)
SII has already produced 25 million doses and aims to further increase production to 100 million doses per year. Credit: Diana Polekhina on Unsplash. The
AHB-137 has been engineered to target CHB. Credit: SewCreamStudio/Shutterstock. AusperBio has raised $37m in a Series A financing round to propel the clinical development of
The agreement leverages Biovac’s expertise in vaccine development and manufacturing. Credit: Diana Polekhina on Unsplash. Sanofi and Biovac have announced a partnership to establish the
The double-blinded and randomised trial enrolled 708 patients. Credit: National Cancer Institute on Unsplash. AstraZeneca has received approval for Truqap (capivasertib) in combination with Faslodex
Share this article Evinova will focus on delivering internationally scaled digital products and offerings. Credit: PopTika / Shutterstock.com. AstraZeneca has launched Evenova, a new digital health
Ergomed is engaged in the outsourced pharma services sector. Credit: Lucas Vasques on Unsplash. Eden AcquisitionCo (Bidco) has signed an agreement to acquire British biopharmaceutical